Zobrazeno 1 - 10
of 240
pro vyhledávání: '"I. Urasiński"'
Autor:
Wieslaw Nowak, Barbara Zdziarska, M Błasińska-Morawiec, M. Dwilewicz-Trojaczek, M. Adamczyk-Cioch, E. Krykowski, Anna Dmoszynska, Trepińska E, M. Kazimierczak, Aleksander B. Skotnicki, Andrzej Hellmann, Z. Kuratowska, Krzysztof Lewandowski, I. Urasiński, Tadeusz Robak
Publikováno v:
Scopus-Elsevier
Eosinophilia and allergic skin reactions are uncommon events after 2-chlorodoxyadenosine (2-CdA, cladribine) administration. A multicentre retrospective analysis of eosinophilia in 360 patients treated with 2-CdA for lymphoid malignancies has been ma
Autor:
Tadeusz Robak, M Komarnicki, Trepińska E, E. Krykowski, Lech Konopka, Anna Dmoszynska, Aleksander B. Skotnicki, Jacek Roliński, M Kaźmierczuk, Wieslaw Nowak, Barbara Zdziarska, J. Hansz, I. Urasiński, Jerzy Z. Blonski, M Błasińska-Morawiec, S. Kotlarek-Haus
Publikováno v:
European Journal of Cancer. 33:2347-2351
2-Chlorodeoxyadenosine (2-CdA) is a new antimetabolite chemotherapeutic agent active in indolent lymphoid malignancies. In this retrospective study, 69 previously untreated patients with B-cell chronic lymphocytic leukaemia (B-CLL) were treated with
Autor:
I, Urasiński
Publikováno v:
Polskie Archiwum Medycyny Wewnetrznej. 100(1)
Autor:
Aleksander B. Skotnicki, J. Błasiński, Barbara Zdziarska, I. Urasiński, Jadwiga Dwilewicz-Trojaczek, S. Kotlarek-Haus, A. Dmoszynska, Kazimierz Hałaburda, M Błasińska-Morawiec, J. Hansz, J. Hołowiecki, Andrzej Hellmann, S. Potoczek, Tadeusz Robak, Lech Konopka
Publikováno v:
Scopus-Elsevier
Between January 1991 and December 1997, 103 patients, 97 with typical hairy cell leukemia (HCL) and 6 with HCL-variant (HCL-V) were treated with 2-chlorodeoxyadenosine (2-CdA) given as 2-h infusion for 5 consecutive d at a daily dose 0.12 mg/kg. To o
Publikováno v:
Polski merkuriusz lekarski : organ Polskiego Towarzystwa Lekarskiego. 4(21)
The treatment of highly of 43 patients with highly malignant non-Hodgkin lymphomas were analysed and assessed. These patients were treated at the Department of Hematology, Pomeranian Medical Academy within 1981-1990. The process was advanced in 76% o
Autor:
J. Opalińska, E. Krykowski, M. Kopera, W. Knopińska-Posłuszny, T. Jackowska, K. Sulek, Tadeusz Robak, A. Hansz, J. Hołowiecki, Wieslaw Nowak, S. Kotlarek-Haus, B. Marianska, M. Kiebiński, R. Rokicka-Milewska, M. Kasznicki, I. Urasiński, Anna Czyż, A. B. Skotnicki, A. Deptała, Z. Kuratowska, H. Spiewak, J. Hansz, Lech Konopka, Andrzej Hellmann, T. Borysewicz-Czajka, A. Dmoszynska
Publikováno v:
Haematology and Blood Transfusion / Hämatologie und Bluttransfusion ISBN: 9783642719622
Acute promyelocytic leukemia (APL) is a distinct subtype of acute myeloid leukemia (AML). It is characterized by an arrest of differentiation at the promyelocytic stage. APL is consistently associated with translo cation between the long arms of chro
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::94aeed50f4f58b89b4975a99612e69a8
https://doi.org/10.1007/978-3-642-71960-8_122
https://doi.org/10.1007/978-3-642-71960-8_122
Autor:
I, Urasiński
Publikováno v:
Polskie Archiwum Medycyny Wewnetrznej. 95(3)
Publikováno v:
Acta haematologica Polonica. 27(1)
Bone marrow abnormalities were assessed in 6 patients with hairy cell leukemia after 2-chlorodeoxyadenosine treatment. In spite of clinical and haematological remission in all patients, hairy cells and fibrosis were found within the marrow. However,
Publikováno v:
Acta haematologica Polonica. 25(3)
The management of stomatitis, commonly complicating intensive chemotherapy in patients with acute leukemias and malignant lymphomas has been presented. The hydrotherapy equipment of our own construction was designed to wash the oral cavity with large
Publikováno v:
Acta haematologica Polonica. 25(4)
DNA-ploidy in lymphoma cells obtained from lymph nodes of 107 patients with non-Hodgkin's lymphomas of low grade malignancy was studied prior to the treatment introduction. The survival of patients was within the range of 24-126 months (median 63 mon